KU-32, a Novel Drug for Diabetic Neuropathy, is Safe for Human Islets and Improves in vitro Insulin Secretion and Viability
MetadataShow full item record
- Pharmacy Scholarly Works 
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.